| P50 | author | Evi X Stavrou | Q58784883 |
| | Silvio Antoniak | Q90480777 |
| P2093 | author name string | Omar Alhalabi | |
| | Chao Fang | |
| | Nigel Mackman | |
| | Alvin H Schmaier | |
| | Alona Merkulova | |
| | Nadja Grobe | |
| P2860 | cites work | Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase | Q24293656 |
| | Defective thrombus formation in mice lacking coagulation factor XII | Q24646366 |
| | Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo | Q24655664 |
| | Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor | Q28299224 |
| | Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice | Q30423011 |
| | Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis | Q33305420 |
| | ACE2 activation promotes antithrombotic activity | Q33611250 |
| | Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator | Q34112923 |
| | WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 |
| | Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein | Q34572652 |
| | Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry. | Q34580630 |
| | Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor | Q34790892 |
| | The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction | Q35148421 |
| | Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins | Q35566578 |
| | Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin | Q35849803 |
| | COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation | Q36229672 |
| | Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation | Q36761576 |
| | The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers | Q36967299 |
| | Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma | Q37020391 |
| | The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets | Q40119975 |
| | Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. | Q40470385 |
| | Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma | Q41814564 |
| | Receptor-mediated internalization of bradykinin. DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways | Q41940728 |
| | Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells | Q42846641 |
| | Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding | Q43121714 |
| | Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation | Q43541656 |
| | Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7). | Q44201695 |
| | Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12. | Q44770285 |
| | The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents | Q47249791 |
| | Fletcher factor deficiency: family study and detection. | Q47879341 |
| | Plasma levels of bradykinin are suppressed in factor XII-deficient mice. | Q51802842 |
| | Kruppel-like factor 4 regulates endothelial inflammation. | Q55043476 |
| | Cyclooxygenase-2–Derived Prostacyclin Regulates Arterial Thrombus Formation by Suppressing Tissue Factor in a Sirtuin-1–Dependent-Manner | Q57398730 |
| | Tissue plasminogen activator release in vivo in response to vasoactive agents | Q69963419 |
| | Bradykinin regulates the expression of kininogen binding sites on endothelial cells | Q70457136 |
| | Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation | Q71401438 |
| | Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein | Q71516712 |
| | Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species | Q72750770 |
| | Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide | Q73762592 |
| | Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases | Q74175903 |
| | Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall | Q80512468 |
| | Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait | Q83593225 |
| | An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals | Q84005909 |
| | Hereditary angioedema: a bradykinin-mediated swelling disorder | Q85888097 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 710-719 | |
| P577 | publication date | 2014-10-22 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor | |
| P478 | volume | 125 | |